Choosing the source of stem cells for allogeneic transplantation: No longer a peripheral issue

被引：25
作者：
Appelbaum, FR
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源：
BLOOD | 1999年 / 94卷 / 02期
关键词：
D O I：
10.1182/blood.V94.2.381.414a48_381_383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：381 / 383
页数：3
相关论文
共 15 条
[1]  
Arpinati M, 1998, BLOOD, V92, p111A
[2]   TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BENSINGER, WI ;
WEAVER, CH ;
APPELBAUM, FR ;
ROWLEY, S ;
DEMIRER, T ;
SANDERS, J ;
STORB, R ;
BUCKNER, CD .
BLOOD, 1995, 85 (06) :1655-1658
[3]   Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation [J].
Bensinger, WI ;
Clift, R ;
Martin, P ;
Appelbaum, FR ;
Demirer, T ;
Gooley, T ;
Lilleby, K ;
Rowley, S ;
Sanders, J ;
Storb, R ;
Buckner, CD .
BLOOD, 1996, 88 (07) :2794-2800
[4]  
Champlin R, 1998, BLOOD, V92, p657A
[5]   Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].
Collins, RH ;
Shpilberg, O ;
Drobyski, WR ;
Porter, DL ;
Giralt, S ;
Champlin, R ;
Goodman, SA ;
Wolff, SN ;
Hu, W ;
Verfaillie, C ;
List, A ;
Dalton, W ;
Ognoskie, N ;
Chetrit, A ;
Antin, JH ;
Nemunaitis, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444
[6]   The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow [J].
Elmaagacli, AH ;
Beelen, DW ;
Opalka, B ;
Seeber, S ;
Schaefer, UW .
BLOOD, 1999, 94 (02) :384-389
[7]   ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS [J].
KORBLING, M ;
PRZEPIORKA, D ;
HUH, YO ;
ENGEL, H ;
VANBESIEN, K ;
GIRALT, S ;
ANDERSSON, B ;
KLEINE, HD ;
SEONG, D ;
DEISSEROTH, AB ;
ANDREEFF, M ;
CHAMPLIN, R .
BLOOD, 1995, 85 (06) :1659-1665
[8]   PRETREATMENT OF DONOR MICE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR POLARIZES DONOR T-LYMPHOCYTES TOWARD TYPE-2 CYTOKINE PRODUCTION AND REDUCES SEVERITY OF EXPERIMENTAL GRAFT-VERSUS-HOST DISEASE [J].
PAN, LY ;
DELMONTE, J ;
JALONEN, CK ;
FERRARA, JLM .
BLOOD, 1995, 86 (12) :4422-4429
[9]   Allogeneic blood stem cell transplantation in advanced hematologic cancers [J].
Przepiorka, D ;
Anderlini, P ;
Ippoliti, C ;
Khouri, I ;
Fietz, T ;
Thall, P ;
Mehra, R ;
Giralt, S ;
Gajewski, J ;
Deisseroth, AB ;
Cleary, K ;
Champlin, R ;
vanBesien, K ;
Andersson, B ;
Korbling, M .
BONE MARROW TRANSPLANTATION, 1997, 19 (05) :455-460
[10]   PRIMARY TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING FACTOR) [J].
SCHMITZ, N ;
DREGER, P ;
SUTTORP, M ;
ROHWEDDER, EB ;
HAFERLACH, T ;
LOFFLER, H ;
HUNTER, A ;
RUSSELL, NH .
BLOOD, 1995, 85 (06) :1666-1672
12